Thyrotoxic periodic paralysis - a retrospective study from Southern India.

IF 3.5 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM
European Thyroid Journal Pub Date : 2024-11-11 Print Date: 2024-12-01 DOI:10.1530/ETJ-24-0164
Jinson Paul, Aneez Joseph, Felix Jebasingh, Atul Ramachandra More, Julie Hephzibah, Kripa Elizabeth Cherian, Nitin Kapoor, Hesarghatta Shyamsunder Asha, Nihal Thomas
{"title":"Thyrotoxic periodic paralysis - a retrospective study from Southern India.","authors":"Jinson Paul, Aneez Joseph, Felix Jebasingh, Atul Ramachandra More, Julie Hephzibah, Kripa Elizabeth Cherian, Nitin Kapoor, Hesarghatta Shyamsunder Asha, Nihal Thomas","doi":"10.1530/ETJ-24-0164","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Thyrotoxic periodic paralysis is a rare manifestation of thyrotoxicosis. Here, we describe the clinical and biochemical features and treatment outcomes of this disorder.</p><p><strong>Methods: </strong>This retrospective study was conducted at a tertiary care centre in southern India. The clinical and biochemical features, treatment received, and therapeutic outcomes of all patients with thyrotoxicosis and acute flaccid paralysis without any other identifiable causes (cases for the study) were compared with an equal number of consecutively selected patients who presented with thyrotoxicosis but without features of paralysis (controls for the study) during the same period.</p><p><strong>Results: </strong>In total, 41 cases and controls were included in this study. The proportion of males was 92.6% and 43.9% in the cases and controls, respectively. The mean age was 32.8 (±7.6) years (cases) and 39.7 (±11.3) years (controls). In the cases, 20% of patients presented without clinical thyrotoxic features. Graves' disease was the most common aetiology of thyrotoxicosis in both groups (92.6% of cases and 87.8% of controls). The prevalence of goitre was significantly higher among controls (90.2%) than among cases (53.7%). The mean serum potassium, free T4, total T4 and total T3 levels were significantly lower in the cases than in the controls. In these cases, two patients had an additional aetiology for persistent hypokalaemia, likely Gitelman's syndrome.</p><p><strong>Conclusion: </strong>This is one of the largest series of thyrotoxic periodic paralysis cases in India. In subjects with thyrotoxicosis, serum potassium, free T4, total T4 and total T3 levels were significantly lower in those with periodic paralysis than in those without.</p>","PeriodicalId":12159,"journal":{"name":"European Thyroid Journal","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Thyroid Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1530/ETJ-24-0164","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"Print","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Thyrotoxic periodic paralysis is a rare manifestation of thyrotoxicosis. Here, we describe the clinical and biochemical features and treatment outcomes of this disorder.

Methods: This retrospective study was conducted at a tertiary care centre in southern India. The clinical and biochemical features, treatment received, and therapeutic outcomes of all patients with thyrotoxicosis and acute flaccid paralysis without any other identifiable causes (cases for the study) were compared with an equal number of consecutively selected patients who presented with thyrotoxicosis but without features of paralysis (controls for the study) during the same period.

Results: In total, 41 cases and controls were included in this study. The proportion of males was 92.6% and 43.9% in the cases and controls, respectively. The mean age was 32.8 (±7.6) years (cases) and 39.7 (±11.3) years (controls). In the cases, 20% of patients presented without clinical thyrotoxic features. Graves' disease was the most common aetiology of thyrotoxicosis in both groups (92.6% of cases and 87.8% of controls). The prevalence of goitre was significantly higher among controls (90.2%) than among cases (53.7%). The mean serum potassium, free T4, total T4 and total T3 levels were significantly lower in the cases than in the controls. In these cases, two patients had an additional aetiology for persistent hypokalaemia, likely Gitelman's syndrome.

Conclusion: This is one of the largest series of thyrotoxic periodic paralysis cases in India. In subjects with thyrotoxicosis, serum potassium, free T4, total T4 and total T3 levels were significantly lower in those with periodic paralysis than in those without.

甲亢性周期性麻痹--来自印度南部的回顾性研究。
目的:甲亢性周期性麻痹是甲亢的一种罕见表现。在此,我们描述了这种疾病的临床和生化特征以及治疗结果:这项回顾性研究在印度南部的一家三级医疗中心进行。方法:这项回顾性研究在印度南部的一家三级医疗中心进行,将所有甲亢合并急性弛缓性麻痹且无任何其他可确定病因的患者(研究病例)与同期连续选取的相同数量的甲亢但无麻痹特征的患者(研究对照组)的临床和生化特征、接受的治疗和治疗结果进行了比较:本研究共纳入 41 例病例和对照组。男性在病例和对照组中所占比例分别为 92.6% 和 43.9%。病例和对照组的平均年龄分别为 32.8 (±7.6) 岁和 39.7 (±11.3) 岁。在病例中,20%的患者无临床甲状腺毒症特征。巴塞杜氏病是两组患者中最常见的甲状腺毒症病因(病例占 92.6%,对照组占 87.8%)。对照组甲状腺肿的发病率(90.2%)明显高于病例(53.7%)。病例的平均血清钾、游离 T4 和总 T3 水平明显低于对照组。在这些病例中,有两名患者的血钾持续偏低,其病因可能是吉特曼综合征:这是印度最大的甲亢周期性麻痹病例系列之一。在甲亢患者中,周期性麻痹患者的血清钾、游离 T4 和总 T3 水平明显低于非周期性麻痹患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Thyroid Journal
European Thyroid Journal Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
6.70
自引率
2.10%
发文量
156
期刊介绍: The ''European Thyroid Journal'' publishes papers reporting original research in basic, translational and clinical thyroidology. Original contributions cover all aspects of the field, from molecular and cellular biology to immunology and biochemistry, from physiology to pathology, and from pediatric to adult thyroid diseases with a special focus on thyroid cancer. Readers also benefit from reviews by noted experts, which highlight especially active areas of current research. The journal will further publish formal guidelines in the field, produced and endorsed by the European Thyroid Association.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信